Stereotactic radiosurgery for recurrent pleomorphic adenoma of the lacrimal gland: a case report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 36241743.
- Also identified by DOI 10.1007/s00701-022-05384-7.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lacrimal gland pleomorphic adenomas (LGPAs) are common, benign, and intraorbital tumours that cause exophthalmos, ptosis, and visual disturbances. The curative treatment for LGPAs is gross total resection, and radiotherapy is considered adjunctive for recurrence or an alternative for inoperable LGPAs. Stereotactic radiosurgery (SRS) can be used for precise delivery of high radiation doses to the tumour, crucial in the treatment of intra-and extracranial neoplasms. Here, we present a 95-year-old woman who had a rapidly growing, recurrent LGPA and was successfully treated with SRS. The tumour was controlled without any adverse events over 21 months following SRS. SRS is a potential alternative treatment for recurrent LGPA.
Medical subject headings
- Lacrimal Apparatus
- Adenoma, Pleomorphic
- Radiosurgery
- Lacrimal Apparatus Diseases
- Eye Neoplasms